Bimode 100 Mg Injection

Name: Bimode 100 Mg Injection
Brand: DRUGS AND DEVICES PHARMA PRIVATE LIMITED
Price: 1794.0 INR
Availability: InStock

Price 1794.0 INR/ Bottle

Get a Price/Quote

MOQ : 10 Units

Bimode 100 Mg Injection Specification

Brand Name
Bimode

Origin of Medicine
india

Life Span
24 Months (Approx.)

Packaging Type
Single Vial in a Monocarton Outer Packaging

Indication
Treatment of Chronic Lymphocytic Leukemia (CLL), Non-Hodgkin Lymphoma (NHL), and Multiple Myeloma.

Salt Composition
Bendamustine Hydrochloride IP 100 mg per vial

Dosage Form
Injection (Lyophilized Powder for Solution)

Pacakaging (Quantity Per Box)
1 Vial/Box

Drug Type
Injection

Ingredients
Bimode Bendamustine Injection IP 100 mg is a premium-quality oncology medicine containing Bendamustine Hydrochloride, an alkylating antineoplastic agent used in the treatment of selected hematological malignancies, including Chronic Lymphocytic Leukemia (CLL) and Indolent B-cell Non-Hodgkin Lymphoma (NHL). Manufactured in accordance with stringent pharmaceutical quality standards, this sterile lyophilized injectable formulation is intended for intravenous administration by qualified healthcare professionals. The product is supplied in secure export-quality packaging suitable for hospitals, oncology centers, pharmaceutical distributors, government procurement agencies, and international buyers. Bulk quantities are available with complete export documentation and customized packaging solutions for global B2B customers.

Physical Form
Powder

Dosage
To be administered only under the supervision of a qualified oncologist. Dosage depends upon body surface area (BSA), treatment protocol, patient age, and clinical condition.

Suitable For
Adults

Quantity
1 Unit

Bimode 100 Mg Injection Trade Information

Minimum Order Quantity
10 Units

Delivery Time
15 Days

Bimode 100 Mg Injection About

Get the latest in oncology care with Bimode 100 Mg Injection, a peerless product containing venerable Bendamustine Hydrochloride IP 100 mg. Highlighted for its prodigious efficacy, Bimode is approved for the treatment of Chronic Lymphocytic Leukemia (CLL), Indolent B-cell Non-Hodgkin Lymphoma (NHL), and Multiple Myeloma in adults. Manufactured in India to rigorous standards, this sterile lyophilized powder is intended for intravenous use in hospital settings by qualified oncologists. Secure monocarton packaging ensures export-quality delivery, making it ideal for global distributors, healthcare establishments, and procurement agencies. Bulk orders and flexible logistics solutions are available, supported by full documentation.

Bimode 100 Mg Injection: Featured Attributes and Applications

Bimode 100 Mg Injection showcases extraordinary versatility, intended for oncology centers, hospitals, and clinical research facilities. Its potent ingredient acts on select hematological malignancies, offering significant therapeutic advantages in treating CLL, NHL, and Multiple Myeloma. Each vial comes as a sterile, lyophilized powder, ensuring optimal dosage precision and stability. Developed for adult patients, it's delivered under expert supervision. The product is acclaimed for its advanced formulation, exceptional safety profile, and high compatibility with existing treatment protocols.

Reliable Supply, Prompt Dispatch, and Secure Packaging

With stock ready for immediate shipment, Bimode 100 Mg Injection exemplifies efficient global delivery through trusted transport services and rapid dispatch timelines. Detailed export documentation facilitates seamless international transactions. Each order is custom-packed in a secure monocarton for maximum protection. Flexible wholesale and bulk supply options cater to B2B buyers, with sample policies available based on client requirements. Hospitals, distributors, and procurement agencies benefit from streamlined logistics geared for timely arrival and product integrity.

FAQ's of Bimode 100 Mg Injection:

Q: How is Bimode 100 Mg Injection administered and who should use it?

A: Bimode 100 Mg Injection is to be administered intravenously, strictly under the supervision of a qualified oncologist. It is suitable for adults diagnosed with Chronic Lymphocytic Leukemia (CLL), Non-Hodgkin Lymphoma (NHL), or Multiple Myeloma.

Q: What are the primary benefits of choosing Bimode 100 Mg Injection?

A: This premium formulation offers prodigious efficacy for hematological malignancies, manufactured according to international standards for safety and reliability. Its sterile, lyophilized powder ensures optimal stability and precise dosing.

Q: Where can Bimode 100 Mg Injection be supplied and distributed?

A: Bimode 100 Mg Injection is available for global hospital networks, oncology centers, pharmaceutical distributors, and government agencies. Bulk quantities and custom packaging solutions can be arranged for B2B clients worldwide.

Q: What is the process for ordering and receiving Bimode 100 Mg Injection internationally?

A: Clients can place bulk orders through pharmaceutical supply channels. Quick dispatch and transport services are provided, with export documentation, ensuring smooth, compliant, and timely international delivery.

Q: When can customers expect delivery after placing an order?

A: Thanks to ready stock and efficient logistics partners, Bimode 100 Mg Injection can generally be dispatched quickly, with delivery timelines varying according to destination and shipping arrangements.

Q: What packaging details should customers expect with Bimode 100 Mg Injection?

A: Each vial is housed in a secure monocarton outer packaging, with every order optimized for protection during transport. Customized packaging options are available for bulk and export orders.

Tell us about your requirement